Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing change for depression.
Multiple locations, including Dothan
This study is recruiting in the United Kingdom, in Belgium, in Austria, .... It is testing Effectiveness and Efficiency of VNS Therapy for depression.
Multiple locations, including ViennaThis study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
Multiple locations, including HomewoodThis study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
Multiple locations, including ChandlerThis study is recruiting in the United States, in Bulgaria, in Croatia, .... It is testing ITI-1284 for Schizophrenia.
Multiple locations, including AnaheimThis study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.
Multiple locations, including PhoenixThis study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.
Multiple locations, including TucsonThis study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including Glendale
This summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study is recruiting in Germany. It is testing digital intervention for depression.
In GermanyThis study is recruiting in Switzerland. It is testing Effects on Sleep and Safety of RE03 for PTSD.
In ZurichThis study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.
Multiple locations, including ChandlerHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.